A Vaxcyte officer told the SEC about a plan to sell $1.65M of Vaxcyte shares around Oct 5, 2026. The filing says the shares were acquired as compensation. That is a tiny part of all Vaxcyte shares.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 144 — Notice of Proposed Sale of Securities

All the details

Dates, kept separate

Planned sale date: Oct 5, 2026
Reporting period: Not applicable
Notice filed with the SEC: Oct 5, 2026

OfficerPlanned saleShares from pay

Context

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001969223-26-001059
Filed / recorded: Oct 6, 2026, 12:10 AM UTC

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Added to OQRO

Oct 7, 2026, 1:40 PM UTC

Parser

form144-v1

Data quality

Read from the record; company matched by name

Issuer

Vaxcyte, Inc.

Issuer CIK

1649094

Table

Non-derivative (Table I)

Transaction date

—

Shares / units

—

Price per share

—

Shares owned after

—

Ownership form

Direct

Amendment

Around the same time

Wassil Jim (Officer) plans to sell ~$1.56M of Vaxcyte

Planned, from payFiled 2d ago

Jim WassilEVP, Chief Scientific Ofc, COO

Filed 4d ago

2,250Shares · @ $5.35

Traded Oct 1 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Jim Wassil (EVP, Chief Scientific Ofc, COO) sold ~$122K of Vaxcyte

Planned saleFiled 4d ago